Blood pressure reduction for the secondary prevention of stroke: a Chinese trial and a systematic review of the literature
Blood pressure reduction for the secondary prevention of stroke: a Chinese trial and a systematic review of the literature is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Blood pressure reduction for the secondary prevention of stroke: a Chinese trial and a systematic review of the literature have?
Blood pressure reduction for the secondary prevention of stroke: a Chinese trial and a systematic review of the literature has 189 citations in the OpenAlex counts ScholarIQ stores.
When was Blood pressure reduction for the secondary prevention of stroke: a Chinese trial and a systematic review of the literature published?
Blood pressure reduction for the secondary prevention of stroke: a Chinese trial and a systematic review of the literature has 2009 year in the ScholarIQ index.
What is the open-access status of Blood pressure reduction for the secondary prevention of stroke: a Chinese trial and a systematic review of the literature?
Blood pressure reduction for the secondary prevention of stroke: a Chinese trial and a systematic review of the literature has bronze oa status in the ScholarIQ index.
What is the DOI of Blood pressure reduction for the secondary prevention of stroke: a Chinese trial and a systematic review of the literature?
The DOI for Blood pressure reduction for the secondary prevention of stroke: a Chinese trial and a systematic review of the literature is on the source record.
What is the PMID of Blood pressure reduction for the secondary prevention of stroke: a Chinese trial and a systematic review of the literature?
The PMID for Blood pressure reduction for the secondary prevention of stroke: a Chinese trial and a systematic review of the literature is on the source record.
What is the OpenAlex record for Blood pressure reduction for the secondary prevention of stroke: a Chinese trial and a systematic review of the literature?
The OpenAlex for Blood pressure reduction for the secondary prevention of stroke: a Chinese trial and a systematic review of the literature is on the source record.